Clinical Trials Logo

Clinical Trial Summary

The main objective of the research is to compare by two blind evaluators new MRI techniques with routinely used sequences.


Clinical Trial Description

"The main evaluation criterion will be the choice of the two (or three) evaluators as to the best sequence between the new sequence and the standard sequence. The decision criterion for considering a new sequence as superior to the standard sequence will be based on two measures: 1. The proportion of patients for whom the new sequence was preferred, which must be greater than or equal to 75%; 2. Inter-observer agreement (Cohen's Kappa coefficient), which must be greater than or equal to 0.8; When these two criteria are met, the new sequence will be considered superior to the standard sequence" ;


Study Design


NCT number NCT05744102
Study type Interventional
Source Assistance Publique - Hôpitaux de Paris
Contact Maïté LEWIN, MD, PHD
Phone (33) 06 11 15 06 17
Email maite.lewin@aphp.fr
Status Not yet recruiting
Phase N/A
Start date March 15, 2023
Completion date March 15, 2030